胎球蛋白
胰岛素抵抗
生物
生物标志物
医学
内科学
糖蛋白
生物信息学
内分泌学
糖尿病
生物化学
作者
Katsuhito Mori,Masanori Emoto,Masaaki Inaba
出处
期刊:Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
日期:2011-05-01
卷期号:5 (2): 124-146
被引量:203
标识
DOI:10.2174/187221411799015372
摘要
Sixty-six years have elapsed since the discovery of fetuin in 1944, but its importance in mammalian physiology has only recently been appreciated. Fetuin, first isolated from fetal bovine serum and now most commonly known as either fetuin-A, alpha-2-HS-glycoprotein (recommended name by UniprotKB and PIR), or α2-Heremans-Schmid glycoprotein, functions as an important component of diverse normal and pathological processes, including vascular calcification and bone metabolism regulation, insulin resistance, protease activity control, keratinocytes migration, and breast tumor cell proliferative signaling. Fetuin-A has also been identified as a biomarker for neurodegenerative disease. Here, we summarize recent publications focusing on the structural and functional properties of fetuin-A. The emerging importance of fetuin-A for both diagnosis and therapeutics has come to the attention of the pharmaceutical industry. Therefore, we will discuss the status of patents based on fetuin-A.
科研通智能强力驱动
Strongly Powered by AbleSci AI